SGI
FBIO icon

Summit Global Investments’s Fortress Biotech FBIO Stock Holding History

Summit Global Investments’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,993
Closed -$145K – 566
2021
Q3 		$145K Buy
+2,993
New +$146K 0.01% 450

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Summit Global Investments's FBIO Position: Q4 2021 in Review

Summit Global Investments sold out of Fortress Biotech (FBIO) in Q4 2021, closing a stake of 2,993 shares — an estimated $145K sold.

Summit Global Investments first reported a position in FBIO in Q3 2021 and held it in 1 quarter. The position peaked at $145K in Q3 2021. 82 funds tracked by Wall St. Rank hold FBIO as of Q4 2021.

  • Summit Global Investments reported no remaining Fortress Biotech position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 2,993 Fortress Biotech shares in Q4 2021, an estimated $145K.
  • Summit Global Investments first reported a position in Fortress Biotech in Q3 2021 and held it in 1 quarter.
  • Summit Global Investments's Fortress Biotech position peaked at $145K in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.